Gambro is a global medical technology company and a leader in developing, manufacturing and supplying products and therapies for Kidney and Liver dialysis, Myeloma Kidney Therapy, and other extracorporeal therapies for Chronic and Acute patients.
Kidney (renal) dialysis was the world’s first extracorporeal therapy (i.e. a therapy that treats organ failure outside the body). Dialysis saves the lives of a growing number of patients every year, and innovation in the field is essential. The only current alternative to renal dialysis - kidney transplantation - is not an available option for most patients, due to a shortage of donor organs.
Dialysis technology is now being developed for new applications such as liver dialysis and an emerging field of other extracorporeal therapies, to remove different fluids and toxins from chronically and acutely ill patients.
For decades, Gambro has been first to market with many groundbreaking innovations. By designing and delivering solutions to dialysis clinics and intensive care units, Gambro offers not just improved treatment quality, but also improved efficiency.
Gambro was founded in 1964 and has today 8 000 employees, 13 production facilities in 9 countries, and sales in more than 90 countries.
|Jul 26, 2016||Business Wire - Baxter Reports Second Quarter 2016 Results and Raises Financial Outlook for Full-Year 2016|
|May 12, 2016||Mass Device - Baxter said to be front-runner in $1.2B race for India’s Gland Pharma|
|Apr 29, 2016||Mass Device - Alere rejected Abbott’s $50m offer to spike merger|
|Apr 29, 2016||Daytona Beach Journal - Braun Medical plans $100M expansion, to nearly triple Daytona workforce|
|Oct 27, 2015||Business Wire - Baxter Reports Strong Third Quarter Financial Results Exceeding Previously Issued Guidance|
|Oct 26, 2015||PRNewswire UK All - Hemoperfusion Market 2019 - 2020 Outlook in New Research Reports|
|Oct 5, 2015||gambro.com - Gambro announces agreement to acquire CHF Solutions, Inc. - Gambro|
|Jul 29, 2015||Business Wire - Baxter Reports Strong Second Quarter Financial Results Exceeding Guidance|
14143 Denver West Parkway
Lakewood, CO 80401